Pigmentation consultation

The consultation covers cause-based assessment of pigmentation patterns: melasma, post-inflammatory hyperpigmentation (PIH) — particularly post-acne marks, sun-induced pigmentation and lentigines, tan-related uneven tone, periorbital and lip pigmentation, neck pigmentation, body pigmentation patterns, and selected mole and lesion review where pigmentation is the presenting concern. The framework deliberately avoids fairness or skin-bleaching framing; the goal is even tone and pigment-clearance where appropriate, not lightening of the patient\'s baseline skin tone.

Different pigmentation patterns respond to different pathways. Melasma calls for a medical-pathway-first framework where in-clinic procedures act as adjuncts to the medical foundation rather than substitutes; PIH typically resolves over months with photoprotection and selected topical pathways; sun-induced lentigines and tan respond differently again; periorbital and lip pigmentation each have their own framing. Treating "pigmentation" as a single concern leads to mismatched pathways and disappointing outcomes.

Melasma is a chronic patchy facial pigmentation pattern with hormonal-axis sensitivity, typically symmetrical across cheeks, forehead, upper lip, and chin, that flares with sun exposure and selected hormonal triggers. PIH (post-inflammatory hyperpigmentation) is the dark-mark response that follows an inflammatory trigger — most commonly acne, but also selected procedural-response and selected injury contexts. Melasma needs ongoing management; PIH typically resolves over months once the trigger is controlled.

Tan and sun-induced pigmentation reflect cumulative ultraviolet exposure rather than a primary medical condition. The framework treats photoprotection (calibrated daily sunscreen, sun-avoidance practices, hat-and-clothing where applicable) as foundational; selected topical actives accelerate the trajectory of fade; selected calibrated procedural pathways support faster fade in some contexts. The framework explicitly avoids rapid skin-bleaching or fairness framing.

Periorbital pigmentation (under-eye and around-eye darkening) and lip pigmentation each have their own assessment framework. Multiple causes contribute — pigment, vascular shadows, fat-pad volume change with age, selected lifestyle factors, selected hormonal contexts. The consultation differentiates the contributing factors rather than treating "dark circles" as a single cosmetic complaint, and the recommendation calibrates accordingly.

Examination assesses the pigmentation pattern under appropriate clinical lighting, often with magnification or Wood\'s lamp where pigment-depth differentiation matters, and with dermoscopy in selected lesion contexts. The framework distinguishes epidermal pigment from dermal pigment because the response trajectory differs substantially. The Wood\'s lamp page covers the framework, and the dermoscopy page covers the broader use.

History covers the timeline of the pigmentation, the triggers the patient associates with flares (sun exposure, hormonal-axis events, particular skincare or medication exposures, post-inflammatory triggers), prior treatment responses, family pattern, and the current skincare regime. Many pigmentation presentations are calibrated by the cumulative interaction of these factors rather than a single discrete cause.

Yes, where the pathway warrants ongoing trajectory assessment. Pigmentation pathways change gradually across months and human visual memory drifts; structured photographic baseline supports objective progress assessment. The patient is informed before any capture and consents at the moment. Default use is clinical-record-only. The pigmentation-pathway photographic framework is documented at the medical photography page.

Selected pigmentation presentations warrant investigation into hormonal-axis context (PCOS, thyroid-axis, selected hormonal medication context) or systemic-condition overlay. Where the picture suggests these the framework requests appropriate blood-work and may collaborate with internal medicine or endocrinology where the case warrants their input. Laboratory work cost sits with the laboratory the patient uses for the tests.

Skincare review is substantive in pigmentation pathways. Many over-the-counter fairness products contain ingredients that can complicate pigmentation pathways or trigger selected reactive responses; the consultation reviews the current regime and discusses whether elements need to be paused or replaced. The framework treats this as part of the assessment rather than as upselling clinic-branded products.

Melasma management is a structured medical-pathway-first framework. Calibrated topical pharmacology (selected ingredient combinations from the standard dermatology toolkit), calibrated daily photoprotection (high-protection sunscreen with adequate UVA coverage, calibrated to the patient\'s skin context), and ongoing trigger-management form the foundation. Procedural adjuncts (selected calibrated chemical peels, selected calibrated low-fluence laser pathways) act as supports rather than substitutes. Maintenance is part of the realistic frame — melasma is managed rather than fixed-permanently-cleared.

PIH management starts with controlling the underlying inflammatory trigger (most commonly acne — see the acne and scars page). Once the trigger is controlled, calibrated photoprotection and selected topical actives support the natural trajectory of fade across months. Selected calibrated procedural touch-points support the timeline in some cases. The framework states honestly that PIH typically takes months to resolve rather than weeks.

The framework integrates daily photoprotection as foundational and adds selected topical actives for cumulative-sun trajectory support. Selected calibrated procedural pathways — for example calibrated Q-switched laser approaches for selected discrete lentigines, with appropriate Indian-skin parameter calibration — support faster clearance in selected presentations. The framework calibrates parameters to the pigmented-skin context rather than running a single setting on every patient.

Periorbital pigmentation is multi-factorial. Calibrated topical pharmacology helps where epidermal pigment is the dominant contributor; vascular-pattern dark-circles need a different framing; fat-pad volume-related shadow benefits more from selected volume-restoration framing where appropriate; selected mixed presentations need a multi-component plan. The framework calibrates the recommendation to the dominant contributing factor rather than promoting a single procedure as the universal answer.

The framework re-orients these requests honestly. The goal of pigmentation pathways is even tone and pigment-clearance where appropriate, not lightening of the patient\'s baseline skin tone. Selected products and selected unregulated pathways promoted in informal channels carry meaningful health risks (selected steroid-containing creams, selected unregulated skin-bleaching agents, selected mercury-containing products). The framework declines to recommend or operate within that frame.

The plan covers the calibrated recommendation, the rationale, the realistic outcome trajectory across an evidence-based timeline (often months for pigmentation pathways), the maintenance pattern (often substantial in melasma), the residual-risk profile, the per-component pricing for the recommended pathway, the photoprotection framework, the proposed follow-up cadence, and any blood-work or referral routing. The plan is patient-side at the end of the visit; patients choose if and when to act on it.

For melasma the realistic outcome is a graded clearance against baseline with maintenance dependency rather than a fixed-final endpoint. For PIH the realistic outcome is a calibrated fade that follows the natural healing trajectory across months. For sun-induced and lentigines pigmentation the realistic outcome is a calibrated lightening of the affected pattern alongside foundation photoprotection. None of these match an rapid clearance promise, and the framework states this honestly.

Pigmented Indian skin has higher post-inflammatory pigmentation risk after thermal, chemical, or laser triggers than less-pigmented skin. The framework calibrates parameters to mitigate this risk, but the residual-risk discussion at consent surfaces it transparently rather than hiding it. Selected pathway choices that overpromise rapid clearance and overshoot the calibrated parameters can produce paradoxical pigmentation responses; the framework deliberately calibrates for the patient\'s skin context.

The dermatology consultation is priced at ₹1,999*. Procedural pathway pricing for pigmentation is structured per-component and is calibrated case-by-case at the consultation rather than displayed as a website list price. Topical pharmacology cost depends on the products recommended; the framework discusses the range at the consultation. The Pricing FAQs covers the framework.

Selected pigmentation pathways operate well across pauses; selected pathways respond best to continuity. Where pause-and-resume questions come up at the consultation the framework discusses the patient-specific trade-offs rather than enforcing a fixed protocol. Patient autonomy around pathway pace is part of the framework rather than against it.

Follow-up cadence is calibrated to the pathway. Active management in melasma typically warrants three-month review windows; PIH typically progresses through months and warrants periodic follow-up to confirm trajectory; lentigines and sun-induced patterns reviewed at the relevant procedural-response window. Photographic baseline-versus-current comparison supports the conversation. The cadence is part of the written plan from the start.

Selected pigmentation pathway follow-ups — particularly continuity reviews where in-person examination is not necessary and selected coordination touch-points — are appropriate for video format. Initial assessment and decisions that depend on hands-on examination are routed in-person. The Teleconsultation Policy in the policies section is the formal source.

Photoprotection is foundational across nearly every pigmentation pathway. The consultation discusses sunscreen selection appropriate for Indian skin (high-protection, adequate UVA coverage, cosmetic acceptability for daily use), application frequency, supportive practices (hat, sunglasses, sun-avoidance windows in peak-UV hours), and the realistic role of photoprotection in the pathway. Adherence to photoprotection often determines pathway response more than the procedural component does.

Pigmentation-pathway records — including any photographic baseline material — are held under the Patient Privacy and Records Policy framework as confidential, access-controlled health information. Access is limited to the dermatologist and trained clinical-team members involved in care; the framework does not pass patient images to external marketing parties without consent. The privacy policy document is the formal source for binding pigmentation-pathway record mechanics.

Where the response does not track the calibrated expectation, the follow-up review is the touch-point for revision conversation. Adjustment options include calibration changes within the active pathway, addition of complementary pathway elements, longer-window observation, or referral where the case warrants specialty input. The framework revises the plan rather than treating the original recommendation as a sunk-cost commitment.